| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11095-008-9721-1 |
| P698 | PubMed publication ID | 18779927 |
| P2093 | author name string | Lynne S Taylor | |
| Tonglei Li | |||
| Patrick J Marsac | |||
| P2860 | cites work | Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. | Q31674692 |
| Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs | Q33748142 | ||
| Biodegradable polymers for ocular drug delivery | Q34243417 | ||
| The mechanisms of drug release from solid dispersions in water-soluble polymers | Q34469709 | ||
| Ocular preparations: the formulation approach | Q34721415 | ||
| Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications | Q35111358 | ||
| Solid Dispersions: Revival with Greater Possibilities and Applications in Oral Drug Delivery | Q35570640 | ||
| In situ forming parenteral drug delivery systems: an overview | Q35857116 | ||
| Nitrate Therapy in Heart Failure | Q36869101 | ||
| Review: photopolymerizable and degradable biomaterials for tissue engineering applications | Q36894312 | ||
| Drug delivery strategies for poorly water-soluble drugs | Q36903806 | ||
| Use of degradable and nondegradable nanomaterials for controlled release | Q36917951 | ||
| Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents | Q36989762 | ||
| Drug release kinetics from stent device-based delivery systems | Q37089617 | ||
| The future of drug-eluting stents | Q37109754 | ||
| Safety and efficacy of the drug-eluting stent: a double-edged sword? | Q37118409 | ||
| Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use. | Q37833289 | ||
| Biomaterials for drug delivery systems | Q38580435 | ||
| Biodegradable polymers in controlled drug delivery | Q38583413 | ||
| The current status of solid dispersions. | Q39734667 | ||
| Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. | Q40294237 | ||
| Role of soft contact lenses and delivery of drugs | Q42136925 | ||
| A spectroscopic investigation of hydrogen bond patterns in crystalline and amorphous phases in dihydropyridine calcium channel blockers | Q44008108 | ||
| Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers | Q44139664 | ||
| Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II. | Q44525198 | ||
| A novel method for deriving true density of pharmaceutical solids including hydrates and water-containing powders | Q47219862 | ||
| Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery. | Q48742123 | ||
| Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. | Q52074288 | ||
| Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates. | Q52335119 | ||
| Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. | Q52528966 | ||
| The ocular tolerability of a new ophthalmic drug delivery system (NODS). | Q54037018 | ||
| [Soft contact lenses impregnated with hypotensive preparations in the treatment of glaucoma] | Q54146195 | ||
| Influence of Different Polymers on the Crystallization Tendency of Molecularly Dispersed Amorphous Felodipine | Q57343249 | ||
| A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems | Q57351431 | ||
| Use of hydrophilic contact lenses to increase ocular penetration of topical drugs | Q71482191 | ||
| Continuous drug delivery through the use of disposable contact lenses | Q72259697 | ||
| Non-isothermal and isothermal crystallization of sucrose from the amorphous state | Q72834299 | ||
| Solubility parameters as predictors of miscibility in solid dispersions | Q73188552 | ||
| What is the true solubility advantage for amorphous pharmaceuticals? | Q73933448 | ||
| Mixing behavior of colyophilized binary systems | Q74602172 | ||
| Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures | Q77214930 | ||
| A study of amorphous molecular dispersions of indomethacin and its sodium salt | Q77358554 | ||
| The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state | Q79184343 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 139-151 | |
| P577 | publication date | 2008-09-09 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters | |
| P478 | volume | 26 |
| Q98578693 | A Mechanistic Model for Predicting the Physical Stability of Amorphous Solid Dispersions |
| Q38619552 | A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME. |
| Q59234104 | A Promising New Method to Estimate Drug-Polymer Solubility at Room Temperature |
| Q87929632 | A new twist in the old story-can compression induce mixing of phase separated solid dispersions? A case study of spray-dried miconazole-PVP VA64 solid dispersions |
| Q38029633 | A review on comb-shaped amphiphilic polymers for hydrophobic drug solubilization |
| Q40027323 | A systematic approach to design and prepare solid dispersions of poorly water-soluble drug |
| Q42930931 | A thermal analysis method to predict the complete phase diagram of drug–polymer solid dispersions |
| Q91603846 | Advances in coamorphous drug delivery systems |
| Q38358879 | Amorphous solid dispersions: a robust platform to address bioavailability challenges |
| Q47967797 | Amorphous-Amorphous Phase Separation in API/Polymer Formulations |
| Q58586198 | An Examination of Water Vapor Sorption by Multi-Component Crystalline and Amorphous Solids and Its Effects on their Solid-State Properties |
| Q92372975 | Analytical and Computational Methods for the Estimation of Drug-Polymer Solubility and Miscibility in Solid Dispersions Development |
| Q49898064 | Antisolvent recrystallization strategy to screen appropriate carriers to stabilize filgotinib amorphous solid dispersions |
| Q42628459 | Atomic Force Microscopy-Based Screening of Drug-Excipient Miscibility and Stability of Solid Dispersions |
| Q47763803 | Building a polysaccharide hydrogel capsule delivery system for control release of ibuprofen |
| Q49092618 | Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying. |
| Q57353648 | Characterization of amorphous solid dispersions |
| Q38411322 | Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques |
| Q64902990 | Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery. |
| Q49496136 | Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability |
| Q42356630 | Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory |
| Q57164849 | Correlation of inhibitory effects of polymers on indomethacin precipitation in solution and amorphous solid crystallization based on molecular interaction |
| Q30620456 | Data mining of solubility parameters for computational prediction of drug-excipient miscibility |
| Q82046241 | Determination of acetaminophen's solubility in poly(ethylene oxide) by rheological, thermal and microscopic methods |
| Q36882127 | Development and evaluation of sustained-release etoposide-loaded poly(ε-caprolactone) implants |
| Q38978159 | Development of a Predictive Model for the Stabilizer Concentration Estimation in Microreservoir Transdermal Drug Delivery Systems Using Lipophilic Pressure-Sensitive Adhesives as Matrix/Carrier. |
| Q46309202 | Development, Physicochemical Characterization and In Vitro Anti-Inflammatory Activity of Solid Dispersions of α,β Amyrin Isolated from Protium Oilresin |
| Q92117240 | Dissolution and permeability properties of co-amorphous formulations of hydrochlorothiazide |
| Q64250399 | Effect of Carrier Lipophilicity and Preparation Method on the Properties of Andrographolide⁻Solid Dispersion |
| Q47189337 | Effect of pH, polymer concentration and molecular weight on the physical state properties of tolfenamic acid |
| Q58617156 | Effects Of Molecular Interactions On Miscibility And Mobility Of Ibuprofen In Amorphous Solid Dispersions With Various Polymers |
| Q59018587 | Effects of Polymeric Additives on the Crystallization and Release Behavior of Amorphous Ibuprofen |
| Q58617159 | Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot Melt Extrusion. I: Miscibility and Drug Release |
| Q46570097 | Electrospun formulations containing crystalline active pharmaceutical ingredients |
| Q38534493 | Enhanced Dissolution and Oral Bioavailability of Piroxicam Formulations: Modulating Effect of Phospholipids |
| Q47852767 | Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method |
| Q84965960 | Evaluation of Predictive Models for Stable Solid Solution Formation |
| Q43273252 | Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. |
| Q45326562 | Evaluation of the recrystallization kinetics of hot-melt extruded polymeric solid dispersions using an improved Avrami equation |
| Q91271768 | Fabrication of Hierarchical Polymeric Thin Films by Spin Coating Toward Production of Amorphous Solid Dispersion for Buccal Drug Delivery System: Preparation, Characterization, and In Vitro Release Investigations |
| Q53584313 | Gaining Thermodynamic Insight From Distinct Glass Formation Kinetics of Structurally Similar Organic Compounds. |
| Q57071123 | Glucosamine-paracetamol spray-dried solid dispersions with maximized intrinsic dissolution rate, bioavailability and decreased levels of in vivo toxic metabolites |
| Q57340445 | Hot Melt Extrusion: A Process Overview and Use in Manufacturing Solid Dispersions of Poorly Water-Soluble Drugs |
| Q50280294 | Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole |
| Q47646957 | Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions |
| Q37896655 | Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations. |
| Q82085136 | Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion |
| Q92411874 | Influence of Glass Forming Ability on the Physical Stability of Supersaturated Amorphous Solid Dispersions |
| Q43145360 | Influence of preparation methods on solid state supersaturation of amorphous solid dispersions: a case study with itraconazole and eudragit e100. |
| Q38170190 | Interactions between drugs and polymers influencing hot melt extrusion. |
| Q87666677 | Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion |
| Q48235393 | Investigation of phase diagrams and physical stability of drug-polymer solid dispersions |
| Q54037823 | Investigation of process temperature and screw speed on properties of a pharmaceutical solid dispersion using corotating and counter-rotating twin-screw extruders. |
| Q42315486 | Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization |
| Q50161058 | Melt extrusion with poorly soluble drugs - An integrated review |
| Q52677367 | Molecular Dynamics Simulation of Amorphous Hydroxypropylmethylcellulose and Its Mixtures With Felodipine and Water. |
| Q85654846 | Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions |
| Q90724131 | Myth or Truth: The Glass Forming Ability Class III Drugs Will Always Form Single-Phase Homogenous Amorphous Solid Dispersion Formulations |
| Q39701492 | Nano self-assemblies based on cholate grafted poly-L-lysine enhanced the solubility of sterol-like drugs |
| Q38619541 | Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters |
| Q38257177 | Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach. |
| Q38791902 | Physicochemical characterization of spray-dried PLGA/PEG microspheres, and preliminary assessment of biological response |
| Q38737245 | Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs |
| Q44837169 | Porous aerosil loading probucol using supercritical carbon dioxide: preparation, in vitro and in vivo characteristics |
| Q47650214 | Predicting Solubility/Miscibility in Amorphous Dispersions: It Is Time to Move Beyond Regular Solution Theories |
| Q45943466 | Prediction of acetaminophen's solubility in poly(ethylene oxide) at room temperature using the Flory-Huggins theory. |
| Q57343786 | Preparation and characterization of a novel pH-sensitive coated microsphere for duodenum-specific drug delivery |
| Q57374595 | Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality |
| Q48244592 | Probing the effects of experimental conditions on the character of drug-polymer phase diagrams constructed using Flory-Huggins theory |
| Q38677413 | Producing Amorphous Solid Dispersions via Co-precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties |
| Q38856865 | Rational excipient selection for co-amorphous formulations |
| Q44690013 | Screening methodologies for the development of spray-dried amorphous solid dispersions. |
| Q46071503 | Solubility Advantage (and Disadvantage) of Pharmaceutical Amorphous Solid Dispersions |
| Q44598171 | Solubility advantage from amorphous etoricoxib solid dispersions |
| Q46216990 | Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA. |
| Q83179706 | Stabilization of a supersaturated solution of mefenamic acid from a solid dispersion with EUDRAGIT(®) EPO |
| Q39227466 | The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions. |
| Q92731084 | The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition Range |
| Q91758332 | The Preparation of Curcumin Sustained-Release Solid Dispersion by Hot Melt Extrusion-Ⅰ. Optimization of the Formulation |
| Q36360522 | The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion |
| Q43025396 | The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine. |
| Q54342597 | The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions. |
| Q45204486 | Theoretical prediction of a phase diagram for solid dispersions |
| Q39424023 | Understanding the tendency of amorphous solid dispersions to undergo amorphous-amorphous phase separation in the presence of absorbed moisture |
| Q38972745 | Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus |
Search more.